Logo

Aussie Genomics Firm Licenses Junk-Gene Patents to Nanogen

Apr 17, 2002

NEW YORK, April 17 - Australian genomics company Genetic Technologies Group has given Nanogen a non-exclusive license to some of its gene patents.

 

Terms of the deal call for Nanogen to fork over about $620,000 in cash and securities in exchange for a number of patents GTG holds for certain non-coding, or junk, regions of human genes, GTG said yesterday.

 

The deal comes on the heels of a similar agreement with Sequenom worth roughly $537,000 signed last week.

 

GTG, a publicly traded company, is based in Melbourne.

Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.